Amid the whirlwind of federal government layoffs over the last few weeks, convenience-store operators, manufacturers, ...

This study received partial support from grants provided by the National Heart, Lung, and Blood Institute of the National Institutes of Health and the Center for Tobacco Products at the Food and Drug ...

The Food and Drug Administration on Monday urged patients and doctors to check that their Ozempic prescriptions are legitimate after the agency seized several hundred units of fake versions of ...

The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that ...

This week, Brian King, the imperious former head of the FDA’s Center for Tobacco Products (CTP), was unceremoniously cashiered from his post and offered a demotion to a regional government office in ...

The U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products has had a change of leadership. The change was overdue. Even though he probably had some good intentions, Dr. Brian King ...

He covers federal public health agencies. Some of the Food and Drug Administration's efforts to support testing for the ongoing bird flu outbreak have been disrupted due to steep layoffs at the ...

The FDA’s Center for Tobacco Products (CTP) Director Brian King has been placed on administrative leave, and dozens of employees at the FDA’s CTP have been dismissed, including two entire ...

The US Food and Drug Administration was supposed to make a final decision about whether or not to approve Novavax's (NVAX) COVID-19 vaccine this week, but that deadline has passed with no clarity ...

Novartis (NVS) “announced the FDA has granted accelerated approval for Vanrafia, or atrasentan, a potent and selective endothelin A receptor antagonist, for the reduction of proteinuria in ...

The tobacco center at the Food and Drug Administration has drawn criticism ... Now King is out at the Center for Tobacco Products, along with Matthew Farrelly, director of the tobacco center ...

called King’s removal “the first step in correcting the broken mindset that has crippled the FDA and the Center for Tobacco Products over the past four years.” ...